News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,627 Results
Type
Article (791)
Company Profile (2)
Press Release (834)
Section
Business (510)
Career Advice (1)
Deals (70)
Drug Delivery (1)
Drug Development (836)
FDA (105)
Job Trends (144)
News (1072)
Policy (360)
Tag
Academia (26)
Alliances (176)
ALS (1)
Alzheimer's disease (4)
Antibody-drug conjugate (ADC) (18)
Approvals (91)
Artificial intelligence (8)
Bankruptcy (1)
Best Places to Work (136)
BIOSECURE Act (1)
Biosimilars (1)
Biotechnology (2)
Brain cancer (1)
Breast cancer (8)
Cancer (74)
Cardiovascular disease (2)
Career advice (2)
Career pathing (1)
CAR-T (2)
CDC (4)
Cell therapy (8)
Clinical research (311)
Collaboration (12)
Complete response letters (2)
COVID-19 (510)
C-suite (9)
Cystic fibrosis (1)
Data (16)
Denatured (3)
Diagnostics (46)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (175)
Editorial (6)
Events (145)
Executive appointments (2)
FDA (111)
Funding (11)
Gene editing (2)
Gene therapy (8)
GLP-1 (17)
Government (193)
Guidances (2)
Healthcare (128)
Huntington's disease (1)
Immunology and inflammation (3)
Immuno-oncology (6)
Infectious disease (516)
Influenza (3)
IPO (33)
IRA (2)
Job creations (12)
Job search strategy (2)
JPM (5)
Labor market (3)
Layoffs (13)
Legal (48)
Lung cancer (27)
Lymphoma (1)
Manufacturing (12)
MASH (2)
Medical device (14)
Medtech (14)
Mergers & acquisitions (41)
Metabolic disorders (14)
mRNA (69)
Neuroscience (5)
NextGen: Class of 2026 (9)
Non-profit (8)
Obesity (11)
Opinion (5)
Pancreatic cancer (2)
Patents (6)
Patient recruitment (2)
People (133)
Phase 1 (154)
Phase 2 (182)
Phase 3 (196)
Pipeline (31)
Policy (18)
Postmarket research (2)
Preclinical (59)
Prostate cancer (1)
Psychedelics (3)
Radiopharmaceuticals (2)
Rare diseases (9)
Real estate (14)
Regulatory (192)
Research institute (39)
RSV (2)
Series A (1)
Series B (3)
Sickle cell disease (1)
Special edition (2)
Startups (11)
Tariffs (2)
The Weekly (10)
Vaccines (200)
Venture capital (2)
Weight loss (3)
Date
Today (3)
Last 7 days (8)
Last 30 days (19)
Last 365 days (128)
2026 (51)
2025 (128)
2024 (167)
2023 (165)
2022 (292)
2021 (353)
2020 (342)
2019 (43)
2018 (29)
2017 (15)
2016 (14)
2015 (14)
2014 (3)
2013 (4)
2012 (7)
Location
Africa (14)
Asia (149)
Australia (7)
California (3)
Canada (6)
China (11)
Colorado (1)
Delaware (1)
Europe (693)
Florida (1)
Indiana (2)
Maryland (12)
Massachusetts (17)
New Jersey (10)
New York (18)
Northern California (1)
Ohio (1)
Pennsylvania (1)
Puerto Rico (1)
South America (5)
United States (64)
1,627 Results for "biontech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs
The action affects BioNTech sites in Germany and Singapore, where the company expects to have excess capacity.
May 5, 2026
·
2 min read
·
Nick Paul Taylor
Antibody-drug conjugate (ADC)
BioNTech, DualityBio tout ‘clinically meaningful’ efficacy for ADC in mid-stage endometrial cancer trial
Trastuzumab pamirtecan, being developed under a 2023 partnership between BioNTech and DualityBio, elicited a 44.1% overall response rate in a Phase 2 trial.
April 13, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot
BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other modalities while mRNA technology continues to face headwinds in the U.S.
April 3, 2026
·
2 min read
·
Nick Paul Taylor
C-suite
BioNTech Founders To Leave Famed mRNA Biotech for New Venture
The move comes as BioNTech shifts to being a multiproduct commercial biotech, allowing Ugur Sahin and Özlem Türeci to transition back into research on next-generation mRNA therapeutics.
March 10, 2026
·
2 min read
·
Annalee Armstrong
Vaccines
Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment
COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data. Moderna is apparently also facing enrollment challenges.
April 2, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
BioNTech Announces New ADS Repurchase Program
May 7, 2026
·
4 min read
Vaccines
Pfizer Makes $530M Vaccine Play With Novavax Deal After Rumors of BioNTech Pullback
In November, Pfizer was reportedly looking to divest its stake in BioNTech, though the German biotech at the time denied these rumors.
January 20, 2026
·
1 min read
·
Tristan Manalac
Vaccines
Pfizer Reportedly Planning To Divest BioNTech Stake
A BioNTech spokesperson downplayed the news, insisting that the two companies remain “close” and have a “strong collaboration.”
November 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
May 5, 2026
·
31 min read
Press Releases
BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026
May 17, 2026
·
4 min read
1 of 163
Next
